Wisconsin Receives Oral Antiviral COVID-19 Treatments

The Department of Health Services (DHS) announced today that Wisconsin has received the first allocation of oral antiviral COVID-19 treatments molnupiravir and Paxlovid to treat patients diagnosed with mild to moderate COVID-19. The initial supply available to states from the federal government is extremely limited. Under guidance developed by the National Institutes of Health (NIH), health care providers are encouraged to prioritize prescribing these new therapeutics to those patients at...(see release)
Source: Wisconsin DHFS Press Releases - Category: Hospital Management Authors: Source Type: news